Essential medicines list For the management of patients admitted to intensive care units with suspected or confirmed COVID-19 diagnosis. Update 10 August 2020
Date
2020Document Number
PAHO/IMS/HSS/COVID-19/20-0031
Metadata
Show full item recordOther Language Versions
Abstract
The list of essential medicines for the management of patients admitted to ICUs with a suspected or confirmed diagnosis of COVID-19 is a core guidance document that provides assistance to countries’ health systems in prioritizing those essential medicines that should be widely available and affordable for the management of patients in ICUs during health emergencies––in this case, for patients with a suspected or confirmed diagnosis of COVID19. This document is targeted to health officials and health system managers in the countries of the Region of the Americas.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2020)This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, ...
-
Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2020)This document updates PAHO's interim recommendations for case management of COVID-19 in health services. Objective of the document: The list of priority medical devices in the context of COVID-19 provides technical ...
-
Pan American Health Organization; Communicable Diseases and Environmental Determinants of Health (CDE) (PAHOUnited StatesWashington, D.C., 2022)Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use ...